These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17627286)

  • 1. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?
    Olsson A; Manzl C; Strasser A; Villunger A
    Cell Death Differ; 2007 Sep; 14(9):1561-75. PubMed ID: 17627286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin-proteasome system is inhibited by p53 protein expression in human ovarian cancer cells.
    Hwang IY; Baguley BC; Ching LM; Gilchrist CA
    Cancer Lett; 2010 Aug; 294(1):82-90. PubMed ID: 20153923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-acetylation interplay activates p53 in response to DNA damage.
    Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
    Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibition up-regulates p53 and apoptosis-inducing factor in chondrocytes causing severe growth retardation in mice.
    Zaman F; Menendez-Benito V; Eriksson E; Chagin AS; Takigawa M; Fadeel B; Dantuma NP; Chrysis D; Sävendahl L
    Cancer Res; 2007 Oct; 67(20):10078-86. PubMed ID: 17942942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed expression of apoptotic and cell-cycle control genes in carcinogen-exposed bladders of mice lacking p53.S389 phosphorylation.
    Bruins W; Jonker MJ; Bruning O; Pennings JL; Schaap MM; Hoogervorst EM; van Steeg H; Breit TM; de Vries A
    Carcinogenesis; 2007 Aug; 28(8):1814-23. PubMed ID: 17317680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct pattern of p53 phosphorylation in human tumors.
    Minamoto T; Buschmann T; Habelhah H; Matusevich E; Tahara H; Boerresen-Dale AL; Harris C; Sidransky D; Ronai Z
    Oncogene; 2001 Jun; 20(26):3341-7. PubMed ID: 11423984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of p53 responses by post-translational modifications.
    Xu Y
    Cell Death Differ; 2003 Apr; 10(4):400-3. PubMed ID: 12719715
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of p53--insights into a complex process.
    Boehme KA; Blattner C
    Crit Rev Biochem Mol Biol; 2009; 44(6):367-92. PubMed ID: 19929178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifications of p53: competing for the lysines.
    Carter S; Vousden KH
    Curr Opin Genet Dev; 2009 Feb; 19(1):18-24. PubMed ID: 19179064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a code embedded in proteins that is based on post-translational modifications?
    Sims RJ; Reinberg D
    Nat Rev Mol Cell Biol; 2008 Oct; 9(10):815-20. PubMed ID: 18784729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gankyrin: a new oncoprotein and regulator of pRb and p53.
    Dawson S; Higashitsuji H; Wilkinson AJ; Fujita J; Mayer RJ
    Trends Cell Biol; 2006 May; 16(5):229-33. PubMed ID: 16581249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox modulation of p53: mechanisms and functional significance.
    Kim DH; Kundu JK; Surh YJ
    Mol Carcinog; 2011 Apr; 50(4):222-34. PubMed ID: 21465572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of p53 in embryonic stem cells.
    Solozobova V; Blattner C
    Exp Cell Res; 2010 Sep; 316(15):2434-46. PubMed ID: 20542030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple post-translational modifications implied in the gene expression regulation: example of the sumoylation of Ets factors].
    de Launoit Y; Degerny C; Wohlkonig A; Baert JL
    Bull Mem Acad R Med Belg; 2007; 162(5-6):299-305; discussion 306. PubMed ID: 18404999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure/function relationships underlying regulation of FOXO transcription factors.
    Obsil T; Obsilova V
    Oncogene; 2008 Apr; 27(16):2263-75. PubMed ID: 18391969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skp2 suppresses p53-dependent apoptosis by inhibiting p300.
    Kitagawa M; Lee SH; McCormick F
    Mol Cell; 2008 Feb; 29(2):217-31. PubMed ID: 18243116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.
    Johnson TM; Attardi LD
    Cell Death Differ; 2006 Jun; 13(6):902-8. PubMed ID: 16557272
    [No Abstract]   [Full Text] [Related]  

  • 18. Crosstalk between site-specific modifications on p53 and histone H3.
    Warnock LJ; Adamson R; Lynch CJ; Milner J
    Oncogene; 2008 Mar; 27(11):1639-44. PubMed ID: 17891183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc.
    Puca R; Nardinocchi L; Bossi G; Sacchi A; Rechavi G; Givol D; D'Orazi G
    Exp Cell Res; 2009 Jan; 315(1):67-75. PubMed ID: 18996371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of phosphorylation in p53 acetylation and PAb421 epitope recognition in baculoviral and mammalian expressed proteins.
    Warnock LJ; Raines SA; Mee TR; Milner J
    FEBS J; 2005 Apr; 272(7):1669-75. PubMed ID: 15794754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.